Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.

Considering the mediation of TERT promoter mutation on the effect of AAD on mortality, inclusion of TERT promoter mutation in a stage classification to achieve further individualized prediction in DTC is necessary.